BTIG Maintains Buy on Compass Pathways, Raises Price Target to $25
Benzinga Newsdesk 3 months ago
Analyst RatingsNewsPrice Target
BTIG analyst Thomas Shrader maintains Compass Pathways (NASDAQ:CMPS) with a Buy and raises the price target from $14 to $25.
BTIG analyst Thomas Shrader maintains Compass Pathways (NASDAQ:CMPS) with a Buy and raises the price target from $14 to $25.